LISATA THERAPEUTICS, INC. Other Non-Current Assets
LISATA THERAPEUTICS, INC. (LSTA) had Other Non-Current Assets of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Noncurrent $0.00.
- 2026-03-31: Other Assets, Noncurrent $23.00K.
- 2025-12-31: Other Assets, Noncurrent $23.00K.
- 2025-09-30: Other Assets, Noncurrent $23.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $23.00K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $23.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $23.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $70.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $116.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $160.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $201.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $246.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $290.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $332.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $371.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $410.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $449.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $528.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $588.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $648.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $708.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $764.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $361.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $450.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $533.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $614.00K 10-K · filed 2022-03-22 | |
| 2020-09-30 | $694.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $772.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $847.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.08M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.31M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $1.40M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.49M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $309.00K 10-K · filed 2020-03-05 | |
| 2018-09-30 | $418.15K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $442.81K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.43M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.72M 10-K · filed 2019-03-14 | $1.43M 10-K · filed 2018-03-22 |
| 2017-09-30 | $1.42M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.40M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $655.50K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $1.58M 10-K · filed 2018-03-22 | $713.45K 10-K · filed 2017-03-17 |
| 2016-09-30 | $726.79K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $812.89K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $894.52K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $976.77K 10-K · filed 2017-03-17 | |
| 2015-09-30 | $1.21M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $1.27M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $1.33M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $1.26M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $1.32M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $1.46M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $1.20M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $1.15M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $973.29K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $990.72K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $979.10K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $947.31K 10-K · filed 2014-03-13 | |
| 2012-09-30 | $932.47K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $3.51M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $6.16M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $3.33M 10-K · filed 2013-03-11 | $5.94M 10-K · filed 2012-03-20 |
| 2011-09-30 | $5.63M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $3.43M 10-Q · filed 2011-08-12 | |
| 2011-01-19 | $581.90K 10-K · filed 2013-03-11 | |
| 2010-12-31 | $2.80M 8-K · filed 2012-08-15 | $2.87M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |